Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 806.9 g/mol |
---|---|
Molecular Formula | C36H70O19 |
XLogP3 | -3 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 19 |
Rotatable Bond Count | 28 |
Exact Mass | 806.45113000 g/mol |
Monoisotopic Mass | 806.45113000 g/mol |
Topological Polar Surface Area | 263 Ų |
Heavy Atom Count | 55 |
Formal Charge | 0 |
Complexity | 986 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 9 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
18
PharmaCompass offers a list of Hydroxypropyl Cellulose API API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hydroxypropyl Cellulose API manufacturer or Hydroxypropyl Cellulose API supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydroxypropyl Cellulose API manufacturer or Hydroxypropyl Cellulose API supplier.
PharmaCompass also assists you with knowing the Hydroxypropyl Cellulose API API Price utilized in the formulation of products. Hydroxypropyl Cellulose API API Price is not always fixed or binding as the Hydroxypropyl Cellulose API Price is obtained through a variety of data sources. The Hydroxypropyl Cellulose API Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LACRISERT manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LACRISERT, including repackagers and relabelers. The FDA regulates LACRISERT manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LACRISERT API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of LACRISERT manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A LACRISERT supplier is an individual or a company that provides LACRISERT active pharmaceutical ingredient (API) or LACRISERT finished formulations upon request. The LACRISERT suppliers may include LACRISERT API manufacturers, exporters, distributors and traders.
click here to find a list of LACRISERT suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A LACRISERT DMF (Drug Master File) is a document detailing the whole manufacturing process of LACRISERT active pharmaceutical ingredient (API) in detail. Different forms of LACRISERT DMFs exist exist since differing nations have different regulations, such as LACRISERT USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A LACRISERT DMF submitted to regulatory agencies in the US is known as a USDMF. LACRISERT USDMF includes data on LACRISERT's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The LACRISERT USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of LACRISERT suppliers with USDMF on PharmaCompass.
LACRISERT Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LACRISERT GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LACRISERT GMP manufacturer or LACRISERT GMP API supplier for your needs.
A LACRISERT CoA (Certificate of Analysis) is a formal document that attests to LACRISERT's compliance with LACRISERT specifications and serves as a tool for batch-level quality control.
LACRISERT CoA mostly includes findings from lab analyses of a specific batch. For each LACRISERT CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LACRISERT may be tested according to a variety of international standards, such as European Pharmacopoeia (LACRISERT EP), LACRISERT JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LACRISERT USP).